Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs

- Cheng, Qinglu, Cunningham, Evan B., Hellard, Margaret, Bruggmann, Philip, Marks, Philippa, Lacombe, Karine, Stedman, Catherine, Read, Phillip, Hajarizadeh, Behzad, Dunlop, Adrian J., Conway, Brian, Feld, Jordan J., Shih, Sophy, Dore, Gregory J., Grebely, Jason, SIMPLIFY and D3FEAT Study Groups,, Amin, Janaki, Bruneau, Julie, Artenie, Adelina A., Powis, Jeff, Litwin, Alain H., Cooper, Curtis, Dalgard, Olav

Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study

- Wheeler, Alice, Valerio, Heather, Matthews, Gail V., Dunlop, Adrian J., Gorton, Carla, Hayllar, Jeremy, Alavi, Maryam, Murray, Carolyn, Marks, Phillipa, Silk, David, Degenhardt, Louisa, Dore, Gregory J., Cunningham, Evan B., Grebely, Jason, Martinello, Marianne, Barocas, Joshua A., Colledge-Frisby, Samantha, Treloar, Carla, Amin, Janaki, Henderson, Charles, Read, Phillip

Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

- Cunningham, Evan B., Amin, Janaki, Dunlop, Adrian J., Norton, Briana, Litwin, Alain H., Hajarizadeh, Behzad, Thurnheer, Maria Christine, Dillon, John F., Weltman, Martin, Shaw, David, Bruggmann, Philip, Gane, Edward, Feld, Jordan J., Fraser, C, Marks, P, Applegate, TL, Quiene, S, Siriragavan, S, Matthews, GV, Dore, GJ, Grebely, J, Bruneau, Julie, Dalgard, Olav, Powis, Jeff, Hellard, Margaret, Cooper, Curtis, Read, Phillip, Conway, Brian

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

- Cunningham, Evan B., Hajarizadeh, Behzad, Swan, Tracy, Marks, Philippa S., Quiene, Sophie, Applegate, Tanya L., Weltman, Martin, Shaw, David, Dunlop, Adrian, Bruneau, Julie, Midgard, Håvard, Bourgeois, Stefan, Dalgard, Olav, Thurnheer, Maria Christine, Dore, Gregory J., Grebely, Jason, Amin, Janaki, Hellard, Margaret, Foster, Graham R., Bruggmann, Philip, Conway, Brian, Backmund, Markus, Robaeys, Geert

Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: the ACTIVATE study

- Midgard, Håvard, Hajarizadeh, Behzad, Hellard, Margaret, Robaeys, Geert, Thurnheer, Marcia C., Weltman, Martin, Amin, Janaki, Marks, Philippa S., Quiene, Sophie, Dore, Gregory J., Dalgard, Olav, Grebely, Jason, Cunningham, Evan B., Conway, Brian, Backmund, Markus, Bruggmann, Philip, Bruneau, Julie, Bourgeois, Stefan, Dunlop, Adrian, Foster, Graham R.

Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

- Grebely, Jason, Dalgard, Olav, Amin, Janaki, Marks, Philippa S., Quiene, Sophie, Applegate, Tanya L., Weltman, Martin, Shaw, David, Dunlop, Adrian, Hellard, Margaret, Bruneau, Julie, Midgard, Håvard, Cunningham, Evan B., Hajarizadeh, Behzad, Foster, Graham R., Bruggmann, Philip, Conway, Brian, Backmund, Markus, Robaeys, Geert, Swan, Tracy